STABILISIERTE ÜBERHALOGENIGEN SÄURELÖSUNGEN

Patent europeic · EP2685832 · En vigur

Inscripziun en il register

Numer da publicaziun: EP2685832
Numer da la dumonda: EP12760461
Gener: Patent europeic cun effect per la Svizra ed il Liechtenstein
Status: En vigur
Scrittira da patent: Concedì
Annunzià: 19-03-2012
Publitgà: 22-01-2014
Concedì: 08-05-2019
La protecziun finescha il pli tard: 18-03-2032
Proxima taxa annuala scadenta: 31-03-2027
Classas IPC: A01N 59/00 (2006.01)
A61K 33/20 (2006.01)
A01P 1/00 (2006.01)
A61P 31/00 (2006.01)
Prioritad: US 201161454383 P 18.03.2011
US 201161526149 P 22.08.2011
Dumonda PCT: PCT/US2012/029650 19.03.2012
Publicaziun PCT: WO2012/129161 27.09.2012
Lingua da l’annunzia: englais
Funtauna: Swissreg

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

01-04-2026
Midada
Published in Swissreg on 01.04.2026
19-08-2025
Adressa dal represchentant midada
Representative
Stolmár & Partner Intellectual Property GmbH, Bahnhofstrasse 11, 6210 Sursee
Published in Swissreg on 19.08.2025
01-04-2025
Midada
Published in Swissreg on 01.04.2025
02-04-2024
Midada
Published in Swissreg on 02.04.2024
01-04-2023
Midada
Published in Swissreg on 01.04.2023
28-08-2019
Owner
Owner
Realm Therapeutics, Inc., 508 Lapp Road, Malvern, PA 19355, USA → Urgo US, Inc., 3801 Hulen Street, Suite 251, Fort Worth, TX 73107, USA
Published in Swissreg on 28.08.2019
08-05-2019
Concedì
Published in Swissreg on 08.05.2019

3801 Hulen Street, Suite 251, Fort Worth, TX 73107, US

Bahnhofstrasse 11, 6210 Sursee